Any way you look at it, it is most likely the world will be a different place once some sense of normality resumes following the global battle against coronavirus. In the new paradigm, there will also be companies riding the wave of a successful confrontation with COVID-19. Will small cap biotech Cytosorbents (CTSO) make such a list?Bucking the trend, the healthcare company skyrocketed 70% year-to-date, on the back of a possible treatment for coronavirus.Last week, Cytosorbents announced that its CytoSorb blood purification device has been used by healthcare providers in Italy, China, Germany and France to treat dozens of severely …read more
Source:: Yahoo Finance
